Back to NISA INVESTMENT ADVISORS, LLC NISA INVESTMENT ADVISORS, LLC

CERECERE
12 quarters

Position history for NISA INVESTMENT ADVISORS, LLCNISA INVESTMENT ADVISORS, LLC's holdings in CEREVEL THERAPEUTICS HLDNG I

NISA INVESTMENT ADVISORS, LLC previously held 0 shares of CERE (CEREVEL THERAPEUTICS HLDNG I), worth $0 as of 2024-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$57,000

Total Shares Change

-2,196

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q3
Latest
Exited
0
-100.0%
$00.0%—
0
2024-Q2
Increased
717
+9.1%
$29,3180.0%—
21
2024-Q1
Increased
657
+9.5%
$27,7710.0%—
21
2023-Q4
Increased
600
+3.5%
$25,4400.0%—
20
2023-Q3
Decreased
580
-65.9%
$12,6610.0%—
0
2023-Q2
Increased
1,700
+19.7%
$54,0430.0%—
24
2023-Q1
Unchanged
1,420
0.0%
$35,0000.0%—
0
2022-Q4
Unchanged
1,420
0.0%
$45,0000.0%—
0
2022-Q3
Increased
1,420
+2.9%
$40,0000.0%—
21
2022-Q2
Increased
1,380
+46.8%
$36,0000.0%—
27
2022-Q1
Decreased
940
-57.2%
$33,0000.0%—
0
2021-Q4
New
2,196
-
$57,0000.0%—
29

Other major holders of CERE: FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used